ALKERMES reported $136K in Pre-Tax Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US USD -26415000 7.15M
Biogen BIIB:US USD 821M 53.8M
Bluebird Bio BLUE:US USD -76513000 16.99M
Coherus Biosciences CHRS:US USD -86650000 36.5M
Heron Therapeutics HRTX:US USD -41882000 14.48M
Horizon Pharma HZNP:US USD 315.1M 27.58M
Intra Cellular Therapies ITCI:US USD -53507000 33.1M
IONIS PHARMACEUT IONS:US USD -47000000 56M
Johnson & Johnson JNJ:US USD 7.42B 655M
Marinus Pharmaceuticals MRNS:US USD 75.04M 114.48M
Minerva Neurosciences NERV:US USD -6901000 1.82M
Nektar Therapeutics NKTR:US USD -59204000 99.76M
Neurocrine Biosciences NBIX:US USD 97.9M 121.2M
Otsuka Holdings 4578:JP JPY 53.21B 8.59B
Pfizer PFE:US USD 10.67B 3.11B
Regeneron Pharmaceuticals REGN:US USD 1.45B 140.6M
Revance Therapeutics RVNC:US USD -83993000 22.56M
Teva Pharmaceutical Industries TEVA:US USD 769M 62M